Fact CheckerSign in

NCT07783893Active, not recruiting

E-Health Literacy Intervention for Bangladeshi Migrants With Type 2 Diabetes in Italy

JACARDI: Intervention to Support E-health Literacy of People Belonging to the Bangladesh Ethnic Minority Affected by Diabetes Mellitus Type 2: an Italian Pilot Study

Source: ClinicalTrials.gov · Last updated 25 Aug 2026

Brief summary (registry, in English)

This study is testing a training program for people from the Bangladeshi community of Ancona in the Marche Region (Italy) who have type 2 diabetes. Many people in this group find it hard to understand health information, including how to use digital health tools. This is called low health literacy. Low health literacy can make it harder to manage diabetes well. The goal of this study is to find out if the training program improves health literacy and confidence in managing diabetes. About 50 adults with type 2 diabetes from the Bangladeshi community are taking part. They are followed by the diabetes clinic at the University Hospital of the Marche Region in Ancona. Before training started, patients, caregivers, and health workers helped design the program together. This made sure the training fit the community's needs and culture. Participants complete a training program with four short modules. The modules cover diabetes, health literacy, and digital skills for managing diabetes. Researchers measure health literacy, digital skills, and confidence in managing diabetes before training, right after training, and again after 1 month and 6 months. This shows whether the improvements last over time. This study is part of JACARDI, a European project working to reduce diabetes and heart disease across Europe.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
14 Aug 2026
Start date
10 Mar 2025
Primary completion date
Dec 2026
Lead sponsor
Marche Region Regional Health Agency
NCT number
NCT07783893

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 10 Mar 2025 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concomitant participation in other studies;

Other illness

  • Failure to meet the inclusion criteria;

Other

  • Lack of written informed consent.

Who the study is looking for

  • belonging to Bangladesh ethnicity
  • affected by DM type 2 (as confirmed by the physician's diagnosis)
  • Followed by the CAD of the capital province of Marche Region, Ancona, located in Azienda Ospedaliero Universitaria delle Marche
  • aged \>= 18 years old
  • Capable of communicating verbally in local language (corresponding to a level of Italian language knowledge =\>A2-CEFR level) (Council of Europe, 1996)
  • without acute medical problems: myocardial infarction or stroke within 6 months, painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility, advanced Parkinson's disease and/or neuromuscular disorders, metastatic cancer, or immunosuppressive therapy, significant visual or hearing impairment, uncontrolled hypertension or other serious conditions that restrict their participation in the study.
  • MMSE\>= 24 (Folstein et al. 1975)
  • PHQ-9=\< 15 (Kroenke et al. 2001)
  • with a low HL level, assessed by a scoring \<=12 of HLS-EU-Q16 (Pelikan et al. 2017) and/or with low e-HL level, measured through e-HEALS (Norman \& Skinner, 2006-II), assessed by a scoring \<=29, and/or with low levels in self-efficacy, measured IT-DMSES (Messina et al. 2018), assessed by a scoring \<4.
  • capable to consent
  • fulfilling the informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Azienda Ospedaliero Universitaria delle Marche (AOU Marche)
Coordinator of this site? Confirm its status
AnconaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.